At the Georgia Cancer Center, we believe in achieving scientific excellence in both basic science and clinical research. We want to recruit innovative scientists who have a passion for patients because tomorrow’s clinical trials begin in the basic science labs today.
Research at the Georgia Cancer Center continues to focus on the most promising pathways for the prevention and treatment of cancer. Our labs include 57 research faculty with a funding portfolio of $16,249,929. This includes 21 NCI-funded grants totaling $7,987,143. To help our research teams make breakthroughs and discover new therapy opportunities, the Georgia Cancer Center's administrative team has curated and created lists of both internal and external grant funding opportunities.
Lisa Middleton
Health Sciences Campus
Georgia Cancer Center - M. Bert Storey Research Building
(706) 721-4566
As you explore the Augusta University Research website, you will find information of value to students and trainees, investigators, research sponsors, and our community, including research participants. You will find web pages for each research area including technology commercialization, sponsored programs, animal research, and human subject research.
At the Georgia Cancer Center, we believe in achieving scientific excellence in both basic science and clinical research. We want to recruit innovative scientists who have a passion for patients because tomorrow’s clinical trials begin in the basic science labs today.
Research at the Georgia Cancer Center continues to focus on the most promising pathways for the prevention and treatment of cancer. Our labs include 57 research faculty with a funding portfolio of $16,249,929. This includes 21 NCI-funded grants totaling $7,987,143. To help our research teams make breakthroughs and discover new therapy opportunities, the Georgia Cancer Center's administrative team has curated and created lists of both internal and external grant funding opportunities.
You can click the individual grant to learn more about application criteria, application deadlines, etc. If you have any questions, feel freet to reach out to Lisa Middleton.
We encourage everybody from graduate students to senior scientists to register for an ORCID account and link it to their eRA Commons personal profile. Starting October 1, 2019, ORCID identifiers will be required for individuals supported by institutional research training, career development, and other research education awards. ORCID iDs will also be required for PD/PIs on individual fellowship and career development applications submitted for due dates on or after January 25, 2020.
At the end of the day, risk avoidance may be the most convincing reason to avoid unrequested hyperlinks. NIH may withdraw your application from consideration if you include them. Don’t risk it. Write a compelling, self-contained grant application and let it speak for itself.
Who funds your current research? Make sure to let NIH know. It is required.
Institutions and investigators must disclose all forms of what is termed “other support” when applying for and receiving NIH grants. Other support includes all resources, regardless of whether or not they have monetary value, available in direct support of an individual’s research endeavors.
So, do you need to report those other NIH grants you have? Yes. What about a contract from another federal agency? Yes. Grants or contracts that go through another institution, including institutions in foreign countries? Yes. Commercial funds? Yes. Domestic or international positions held by senior/key personnel? Yes. In kind lab or office space? Yes. Scientific materials? Yes. Even if it has no monetary value? Yes. Affiliations (even if described as honorary or adjunct) with foreign entities or governments, including talents programs? Yes.
Applicants are reminded they must promptly notify NIH if previously submitted just-in-time information is substantively changed prior to award or at the time of the progress report, which could lead to budgetary, scientific, or commitment overlap.
If you are new to writing grant applications, sometimes seeing how someone else has presented their idea can help as you are developing your own application. With the gracious permission of successful investigators, the National Institute of Allergy and Infectious Diseases (NIAID) makes available examples of funded R01, R03, R15, R21, SBIR/STTR, K, and F applications, summary statements, sharing plans, leadership plans, and more.
Check out the NIAID’s Sample Applications and More.
When referencing these resources, it is important to remember:
No. Only a single resubmission of a competing new, revision, or renewal application (A0) will be accepted. After a resubmission of a competing renewal (Type 2) application that is not funded, a subsequent new renewal (Type 2 A0) application may not be submitted. The next application submitted on this topic should be submitted as a new application (Type 1 A0) on an appropriate due date for new applications (see NOT-OD-18-197 for exceptions).